日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Disease progression more than 6 years after treatment impacts overall survival in mantle cell lymphoma

套细胞淋巴瘤患者治疗6年后疾病进展会影响总体生存期。

Ekberg, Sara; Glimelius, Ingrid; Albertsson-Lindblad, Alexandra; Smedby, Karin E; Jerkeman, Mats; Dietrich, Caroline E

Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2/3 superiority trial

伊布替尼联合利妥昔单抗对比免疫化疗治疗既往未接受治疗的套细胞淋巴瘤患者(ENRICH):一项随机、开放标签、2/3期优效性试验

Lewis, David J; Jerkeman, Mats; Sorrell, Lexy; Wright, David; Glimelius, Ingrid; Poulsen, Christian B; Pasanen, Annika; Rawstron, Andrew; Wader, Karin F; Morley, Nick; Burton, Catherine; Davies, Andrew J; Lagerlöf, Ingemar; Dalal, Surita; De Tute, Ruth; McNamara, Chris; Crosbie, Nicola; Toldbod, Helle Erbs; Sanders, Jeanette; Allgar, Victoria; Aroori, Sree; Warner, Mark; Scully, Claire; Wainman, Brian; Christensen, Jacob Haaber; Riise, Jon; Sonnevi, Kristina; Bishton, Mark J; Eyre, Toby A; Rule, Simon

EHA-EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma

EHA-EU MCL 网络套细胞淋巴瘤诊断和治疗指南

Jerkeman, Mats; Aurer, Igor; Campo, Elias; Cheah, Chan Y; Clark, Jonathan; Doorduijn, Jeanette; Eyre, Toby A; Fehr, Martin; Giné, Eva; Gomes da Silva, Maria; Klener, Pavel; Ladetto, Marco; Ribrag, Vincent; Shpilberg, Ofer; Walewski, Jan; Dreyling, Martin

Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment, and follow-up

外周T细胞和自然杀伤细胞淋巴瘤:ESMO-EHA临床实践指南(诊断、治疗和随访)

d'Amore, Francesco; Federico, Massimo; de Leval, Laurence; Ellin, Fredrik; Hermine, Olivier; Kim, Won Seog; Lemonnier, François; Vermaat, Joost S P; Wulf, Gerald; Buske, Christian; Dreyling, Martin; Jerkeman, Mats

Limited stage mantle cell lymphoma: A real-world study of primary treatment and prognosis in Sweden 2006-2018

局限期套细胞淋巴瘤:2006-2018年瑞典一线治疗和预后的真实世界研究

Albertsson-Lindblad, Alexandra; Ekberg, Sara; Glimelius, Ingrid; Ellin, Fredrik; Sonnevi, Kristina; Lewerin, Catharina; Brandefors, Lena; Smedby, Karin E; Jerkeman, Mats

Ibrutinib, lenalidomide, and rituximab in relapsed mantle cell lymphoma: Long-term follow-up of the Nordic Lymphoma Group MCL6 Philemon trial

伊布替尼、来那度胺和利妥昔单抗治疗复发性套细胞淋巴瘤:北欧淋巴瘤组 MCL6 Philemon 试验的长期随访

Forsgren, Elin; Jørgensen, Rasmus R K; Bentzen, Hans; Riise, Jon; Haaber, Jacob; Pasanen, Annika; Kuitunen, Hanne; Wader, Karin F; El-Galaly, Tarec C; Hutchings, Martin; Glimelius, Ingrid; Jerkeman, Mats

Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study

LYSA 研究通过对 1280 例参与临床试验的套细胞淋巴瘤患者进行分析,验证了 POD24 作为套细胞淋巴瘤早期预后不良的可靠临床指标的有效性。

Sarkozy, Clémentine; Chartier, Loïc; Ribrag, Vincent; Gressin, Remy; Geisler, Christian H; Kluin-Nelemans, Hanneke C; Thieblemont, Catherine; Morschhauser, Franck; Lemonnier, François; Safar, Violaine; Tessoulin, Benoît; Oberic, Lucie; Damaj, Ghandi; Ghesquières, Hervé; Bouabdallah, Krimo; Casasnovas, René Olivier; Houot, Roch; Klapper, Wolfram; Burroni, Barbara; Pott, Christiane; Delfau-Larue, Marie-Hélène; Macintyre, Elizabeth; Callanan, Mary; Jerkeman, Mats; Unterhalt, Michael; Hoster, Eva; Dreyling, Martin; Le Gouill, Steven; Hermine, Olivier; Cheminant, Morgane

Circulating tumor DNA determinants of response and outcome in relapsed/refractory mantle cell lymphoma

循环肿瘤DNA在复发/难治性套细胞淋巴瘤的治疗反应和预后中的决定因素

Meriranta, Leo; Rask Kragh Jørgensen, Rasmus; Pasanen, Annika; Kolstad, Arne; Hutchings, Martin; Niemann, Carsten Utoft; El-Galaly, Tarec Christoffer; Riise, Jon; Christensen, Jacob Haaber; Sonnevi, Kristina; Pedersen, Lone Bredo; Wader, Karin Fahl; Glimelius, Ingrid; Leppä, Sirpa; Jerkeman, Mats

Temporal trends in relative survival of diffuse large B-cell lymphoma in Sweden and Denmark in the era of targeted and cellular therapies

瑞典和丹麦在靶向和细胞疗法时代弥漫性大B细胞淋巴瘤相对生存率的时间趋势

Harrysson, Sara; Eloranta, Sandra; Antonilli, Stefanie; Runason Simonsen, Mikkel; Sonnevi, Kristina; Brown, Peter; Wahlin, Bjorn E; Andersson, Per-Ola; Jørgensen, Judit M; Jerkeman, Mats; Poulsen, Christian B; Enblad, Gunilla; El-Galaly, Tarec C; Smedby, Karin E

Inter-reader agreement of quantitative FDG PET/CT biomarkers in lymphoma: a multicentre evaluation of MTV, TLG and Dmax

淋巴瘤定量FDG PET/CT生物标志物的阅片者间一致性:MTV、TLG和Dmax的多中心评估

Trägårdh, Elin; Lewold, Malin; Urdaneta, Jesus Lopez; Larsson, Måns; Enqvist, Olof; Barrington, Sally F; Jerkeman, Mats; Edenbrandt, Lars; Sadik, May